July 2008 - For patients receiving kidney transplants, treatment with cholesterol-lowering "statin" drugs may lead to longer survival, reports a study in the November 2008 Journal of the American Society of Nephrology (JASN).

July 2008 - A great deal of scientific evidence shows that cholesterol-reducing medications known as statins can help prevent coronary artery disease. Although the safety of these medications has been well documented, as many as 40 percent of patients who receive a prescription for statins take the drug for less than one year.

Doctors believe that several factors -- including cost, adverse effects, poor understanding of statin benefits and patients' reluctance to take prescription medications long term -- may explain why some patients stop taking these medicines.

August 2008 - Cholesterol, both good and bad, gets plenty of attention when the subject is reducing the risk of heart disease. Yet triglycerides, a form of fat that circulates in the blood, merit similar attention, according to the August issue of Mayo Clinic Health Letter.

Some studies suggest that the increase in heart disease risk from elevated triglycerides may rival that of high low-density lipoprotein (LDL) or "bad" cholesterol. Another concern is that high triglyceride levels increase the risk of pancreatitis, a painful, life-threatening inflammation of the pancreas.